A Trypanosoma brucei bloodstream form mutant deficient in ornithine decarboxylase can protect against wild-type infection in mice

Experimental Parasitology

Volumn 91, Issue 2, 1999, Pages 176-184

  Mutomba, Martha C ^a   Li, Fengsheng ^b   Gottesdiener, Keith M ^b   Wang, Ching C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Columbia Coll of Phys and Surgeons ^*  (United States)

Author keywords

Immunity; Ornithine decaboxylase; Trypanosoma brucei; Variant surface glycoprotein

Indexed keywords

ORNITHINE DECARBOXYLASE;

ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; GENE MUTATION; HUMORAL IMMUNITY; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PARASITE VIRULENCE; PARASITEMIA; PATHOGENESIS; PRIORITY JOURNAL; TRYPANOSOMA BRUCEI; TRYPANOSOMIASIS;

ANIMALIA; MAMMALIA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA BRUCEI;

EID: 0032811558     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1998.4363     Document Type: Article

References (28)

1. Bacchi C. J., Nathan H. C., Hutner S. H., McCann P. P., Sjoerdsma A. Polyamine metabolism: A potential therapeutic target in trypanosomes. Science. 210:1980;332-334.
2. Bacchi C. J., Yarlett N., Goldberg B., Bitonti A. J., McCann P. P. Polyamine metabolism in African trypanosomes. Biochemical Protozoology. 1991;Taylor & Francis, London. p. 469-481.
3. Balasundaram D., Dinman D. J., Wickner R. B., Tabor C. W., Tabor H. Spermidine deficiency increases +1 ribosomal frameshifting efficiency and inhibitsTy1Saccharomyces cerevisae. Proceedings of the National Academy of Science USA. 91:1994;172-176.
4. Boothroyd J. C. Antigenic variation in African trypanosomes. Annual Review of Microbiology. 37:1985;475-502.
5. Cross G. A. M. Cellular and genetic aspects of antigenic variation in trypanosomes. Annual Review of Immunology. 8:1990;83-110.
6. Crowe J. S., Barry J. D., Luckins A. G., Ross C. A., Vickerman K. All metacyclic variable antigen types ofTrypanosoma congolense. Nature. 306:1983;389-391.
7. Cunningham I. New culture medium for maintenance of tsetse tissues and growth of trypanosomatids. J. Protozool. 24:1977;325-329.
8. Graham S. V., Matthews K. R., Shiels P. G., Barry J. D. Distinct, developmental stage-specific activation mechanisms of trypanosome VSG genes. Parasitology. 101:1990;361-367.
9. Hirumi H., Hirumi K. J. Continuous cultivation ofTrypanosoma brucei. Journal of Parasitology. 75:1989;985-989.
10. Kitamura D., Rajewsky K. Targetted disruption of mu chain membrane exon causes loss of heavy chain allelic exclusion. Nature. 356:1992;154-156.
11. Kitamura D., Roes J., Kuhn R., Rajewsky K. A B-cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobin mu chain gene. Nature. 350:1991;423-426.
12. Kuzoe F. A. S. Perspectives in research on and control of African trypanosomiasis. Annual Tropical Medicine Parasitology. 85:1991;33-41.
13. Kuzoe F. A. S. Current situation of African trypanosomiasis. Acta Tropical. 54:1993;153-162.
14. Li F., Gottesdiener K. M. An efficient method for stable transfection of bloodstream-formTrypanosoma brucei. Nucleic Acids Research. 24:1996;534-535.
15. Li F., Hua S.-b., Wang C. C., Gottesdiener K. M. ProcyclicTrypanosoma brucei. Molecular and Biochemical Parasitology. 78:1996;227-236.
16. Loser C., Folsch U. R., Paprotny C., Creutzfeldt W. Polyamine concentrations in pancreatic tissue, serum and urine of patients with pancreatic cancer. Pancreas. 5:1990;119-127.
17. Mombaerts P., Clarke A. R., Rudnicki M. A., Lacomini J., Itohara S., Lafaille J. J., Wang L., Ichikawa Y., Jaenisch R., Hooper M. L., Tonegawa S. Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stages. Nature. 360:1992;225-231.
18. Mutomba M. C., Wang C. C. Differentiation of a culture-adapted mutant bloodstream form ofTrypanosoma brucei. Molecular and Biochemical Parasitology. 72:1995;215-225.
19. Pastorian K. E., Byus C. V. Tolerance to putrescine toxicity in Chinese hamster ovary cells is associated with altered uptake and export. Experimental Cell Research. 231:1997;284-295.
20. Phillips M. A., Coffino P., Wang C. C. Cloning and sequencing of the ornithine decarboxylase gene fromTrypanosoma brucei. Journal of Biological Chemistry. 262:1987;8721-8727.
21. Poulin R., Lu L., Ackermann B., Bey P., Pegg A. E. Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by α-difluoromethylornithine: Characterization of sequences at the inhibitor and coenzyme binding sites. Journal of Biological Chemistry. 267:1992;150-158.
22. Reinitz D. M., Mansfield J. M. T-cell-independent and T-cell-dependent B-cell responses to exposed variant surface glycoprotein epitopes in trypanosome-infected mice. Infection and Immunity. 58:1990;2337-2342.
23. Shinkai Y., Rathbun G., Lam K. P., Oltz E. M., Stewart V., Mendelsohn M., Charron J., Datta M., Young F., Stall A. M., Alt. F. W. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 68:1992;855-867.
24. Sommer J. M., Hua S.-b., Li F. S., Gottesdiener K. M., Wang C. C. Cloning by functional complementation inTrypanosoma brucei. Molecular and Biochemical Parasitology. 76:1996;83-89.
25. Tabor C. W., Tabor H. Polyamines. Annual Review of Biochemistry. 53:1984;749-790.
26. Tonegawa S. Somatic generation of antibody diversity. Nature. 302:1983;575-581.
27. Vickerman K. Developmental cycles and biology of pathogenic trypanosomes. British Medical Bulletin. 41:1985;105-114.
28. Wang C. C. Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis. Annual Review of Pharmacology and Toxicology. 35:1995;93-127.